
Rainville’s role includes leading the growth of Milpitas, California–based Bigfoot Biomedical’s fully commercial Bigfoot Unity diabetes management program as the company looks to expand access to its offerings.
Bigfoot Unity aims to simplify CGMs and the data they produce to tell people how much insulin to take at a given point in time. It’s comprised of a smart insulin pen cap, which takes data from a CGM and informs the patient of exactly how much insulin they need.
The company has partnered with Abbott and the FreeStyle Libre 2 CGM sensor that integrates into its system, with the pen caps “talking” to the FreeStyle Libre as part of the all-encompassing design of Bigfoot Unity.
Get the full story at our sister site, Drug Delivery Business News.